Hypermarcas (OTCMKTS:HYPMY) Shares Gap Down - Here's Why

Key Points

• Hypermarcas shares gapped down significantly, opening at $4.21 after closing at $4.53, with the stock trading recently at $4.29.
• Scotiabank upgraded Hypermarcas to a "strong-buy" rating on July 17th, indicating potential confidence in the company's future performance.
• The company has recently announced a dividend of $0.0345 per share, yielding an extraordinary 281%, to be paid to shareholders of record on July 1st.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) gapped down prior to trading on Monday . The stock had previously closed at $4.53, but opened at $4.21. Hypermarcas shares last traded at $4.29, with a volume of 535 shares traded.

Wall Street Analysts Forecast Growth

Separately, Scotiabank raised shares of Hypermarcas to a "strong-buy" rating in a research note on Thursday, July 17th.

Hypermarcas Trading Up 4.6%

The company has a current ratio of 1.26, a quick ratio of 0.80 and a debt-to-equity ratio of 0.63. The company's fifty day moving average is $4.72 and its 200-day moving average is $4.01. The firm has a market capitalization of $2.68 billion, a P/E ratio of 20.12 and a beta of 0.77.

Hypermarcas (OTCMKTS:HYPMY - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported $0.12 earnings per share (EPS) for the quarter. Hypermarcas had a net margin of 11.28% and a return on equity of 6.19%.

Hypermarcas Dividend Announcement

The firm also recently disclosed a dividend, which will be paid on Friday, January 8th. Stockholders of record on Tuesday, July 1st will be issued a dividend of $0.0345 per share. This represents a dividend yield of 281.0%. The ex-dividend date of this dividend is Monday, June 30th. Hypermarcas's dividend payout ratio (DPR) is presently 57.14%.

Hypermarcas Company Profile

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.